litlas
Log inCreate account

Tito Fojo

Active 1995–2025

113
Papers
29,504
Citations
83
h-index
110
i10-index

Citations

Citations per year for Tito Fojo1993: 1 citations1995: 1 citations1996: 3 citations1997: 20 citations1998: 56 citations1999: 97 citations2000: 164 citations2001: 210 citations2002: 204 citations2003: 280 citations2004: 285 citations2005: 349 citations2006: 317 citations2007: 312 citations2008: 289 citations2009: 322 citations2010: 299 citations2011: 317 citations2012: 312 citations2013: 313 citations2014: 336 citations2015: 293 citations2016: 255 citations2017: 309 citations2018: 246 citations2019: 750 citations2020: 730 citations2021: 677 citations2022: 433 citations2023: 326 citations2024: 479 citations2025: 212 citations2026: 5 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,340 citing papers, 28.9% of this breakdownChina: 1,269 citing papers, 11% of this breakdownGermany: 593 citing papers, 5.1% of this breakdownUnited Kingdom: 551 citing papers, 4.8% of this breakdownItaly: 534 citing papers, 4.6% of this breakdownFrance: 437 citing papers, 3.8% of this breakdownJapan: 377 citing papers, 3.3% of this breakdownCanada: 334 citing papers, 2.9% of this breakdownNetherlands: 318 citing papers, 2.7% of this breakdownIndia: 295 citing papers, 2.5% of this breakdownAustralia: 263 citing papers, 2.3% of this breakdownSpain: 233 citing papers, 2% of this breakdown
0%28.9%Other 26.1%

Institutions

Fields

  • Medicine52%
  • Biochemistry, Genetics and Molecular Biology33.2%
  • Materials Science3.3%
  • Engineering2%
  • Computer Science2%
  • Immunology and Microbiology1.8%
  • Other5.7%

Topics

  • Drug Transport and Resistance Mechanisms5.9%
  • Cancer Cells and Metastasis3.6%
  • Cancer, Hypoxia, and Metabolism3%
  • Adrenal and Paraganglionic Tumors2.3%
  • Cancer-related Molecular Pathways2.1%
  • Microtubule and mitosis dynamics2.1%
  • Other81%

Coauthors

All papers

Open in search
  1. Multidrug resistance in cancer: role of ATP–dependent transporters

    Authors: Michael M. Gottesman, Tito Fojo, Susan E. Bates - Nature reviews. Cancer 2002 cited by 5,519

  2. Tumour stem cells and drug resistance

    Authors: Michael Dean, Tito Fojo, Susan E. Bates - Nature reviews. Cancer 2005 cited by 3,658

  3. Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Authors: Martin Faßnacht, Massimo Terzolo, Bruno Allolio, Éric Baudin, Harm R. Haak, Alfredo Berruti, Staffan Welin, Carmen Schade‐Brittinger, André Lacroix, Barbara Jarząb, Halfdan Sørbye, David J. Torpy, Vinzenz Stepan, D.E. Schteingart, Wiebke Arlt, Matthias Kroiß, Sophie Leboulleux, Paola Sperone, Anders Sundin, I G C Hermsen, Stefanie Hahner, Holger S. Willenberg, Antoine Tabarin, Marcus Quinkler, Christelle de la Fouchardière, Martin Schlumberger, Franco Mantero, Dirk Weismann, Felix Beuschlein, Hans Gelderblom, Hanneke Wilmink, Monica Sender, Maureen Edgerly, W. Kenn, Tito Fojo, Hans‐Helge Müller, Britt Skogseid - New England Journal of Medicine 2012 cited by 864

  4. Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis

    Authors: Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S. Moskowitz, Firas Ahmed, Volkan Beylergil, Dana E. Connors, Hao Yang, Lin Lü, Tito Fojo, Richard D. Carvajal, Sanja Karovic, Michael L. Maitland, Gregory Goldmacher, Geoffrey R. Oxnard, Michael A. Postow, Lawrence H. Schwartz - JAMA Oncology 2022 cited by 92

  5. Delivering affordable cancer care in high-income countries

    Authors: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 cited by 714

  6. The Role of ABC Transporters in Clinical Practice

    Authors: Gregory D. Leonard, Tito Fojo, Susan E. Bates - The Oncologist 2003 cited by 823

  7. SomaticHIF2AGain-of-Function Mutations in Paraganglioma with Polycythemia

    Authors: Zhengping Zhuang, Chunzhang Yang, Felipe Lorenzo, Maria J. Merino, Tito Fojo, Electron Kebebew, Vera Popović, Constantine A. Stratakis, Josef T. Prchal, Karel Pacák - New England Journal of Medicine 2012 cited by 392

  8. Mitosis is not a key target of microtubule agents in patient tumors

    Authors: Edina Komlódi-Pásztor, Dan L. Sackett, Julia Wilkerson, Tito Fojo - Nature Reviews Clinical Oncology 2011 cited by 306

  9. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

    Authors: David Taïeb, Svenja Nölting, Nancy D. Perrier, Martin Faßnacht, Jorge A. Carrasquillo, Ashley Grossman, Roderick Clifton‐Bligh, George B. Wanna, Zachary G. Schwam, Laurence Amar, Isabelle Bourdeau, Ruth Casey, Joakim Crona, Cheri Deal, Jaydira Del Rivero, Quan‐Yang Duh, Graeme Eisenhofer, Tito Fojo, Hans K. Ghayee, Anne‐Paule Gimenez‐Roqueplo, Anthony J. Gill, Rodney J. Hicks, Alessio Impériale, Abhishek Jha, Michiel N. Kerstens, Ronald R. de Krijger, André Lacroix, Ivica Lazúrová, Frank I. Lin, Charlotte Lussey‐Lepoutre, Eamonn R. Maher, Özgür Mete, Mitsuhide Naruse, Naris Nilubol, Mercedes Robledo, F. Sébag, Nalini S. Shah, Akiyo Tanabe, Geoffrey B. Thompson, Henri Timmers, J Widimský, William J. Young, Leah Meuter, Jacques W.M. Lenders, Karel Pacák - Nature Reviews Endocrinology 2023 cited by 90

  10. Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas

    Authors: David Taïeb, Alexandre Kaliski, Carsten C. Boedeker, Victoria Martucci, Tito Fojo, John R. Adler, Karel Pacák - Endocrine Reviews 2014 cited by 168

  11. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

    Authors: Keisuke Miyake, Lyn A. Mickley, Thomas Litman, Zhirong Zhan, Robert W. Robey, B Cristensen, Mariafiorella Brangi, L Greenberger, Michael Dean, Tito Fojo, Susan E. Bates - 1999 cited by 822

  12. Characteristics And Outcomes Of Metastatic Sdhb And Sporadic Pheochromocytoma/Paraganglioma: An National Institutes Of Health Study

    Authors: Hana Turková, Tamara Prodanov, Marek Malý, Victoria Martucci, Karen T. Adams, J Widimský, Clara C. Chen, Alexander Ling, Electron Kebebew, Constantine A. Stratakis, Tito Fojo, Karel Pacák - Endocrine Practice 2015 cited by 134

  13. Precision oncology: origins, optimism, and potential

    Authors: Vinay Prasad, Tito Fojo, Michael Brada - The Lancet Oncology 2016 cited by 256

  14. Metastatic Pheochromocytoma/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB Mutations

    Authors: Kathryn S. King, Tamara Prodanov, Vitaly Kantorovich, Tito Fojo, Jacqueline Hewitt, Margaret Zacharin, Robert Wesley, Maya Lodish, Margarita Raygada, Anne‐Paule Gimenez‐Roqueplo, Shana E. McCormack, Graeme Eisenhofer, Dragana Milosevic, Electron Kebebew, Constantine A. Stratakis, Karel Pacák - Journal of Clinical Oncology 2011 cited by 198

  15. A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

    Authors: Ronan J. Kelly, Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz, Xiaohong Chen, Erin R. Gardner, Frank M. Balis, Aradhana M. Venkatesan, Seth M. Steinberg, Tito Fojo, Susan E. Bates - Clinical Cancer Research 2010 cited by 172

  16. The evidence framework for precision cancer medicine

    Authors: Jeffrey A. Moscow, Tito Fojo, Richard L. Schilsky - Nature Reviews Clinical Oncology 2017 cited by 168

  17. Emerging Therapeutic Implications of STK11 Mutation: Case Series

    Authors: Bahar Laderian, Prabhjot S. Mundi, Tito Fojo, Susan E. Bates - The Oncologist 2020 cited by 56

  18. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

    Authors: Hui Huang, Jame Abraham, Elizabeth Hung, Steven D. Averbuch, Maria J. Merino, Seth M. Steinberg, Karel Pacák, Tito Fojo - Cancer 2008 cited by 252

  19. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

    Authors: Olivier Rixe, Waldo Ortuzar, Manuel Álvarez, R. R. Parker, Eddie Reed, K Paull, Tito Fojo - Biochemical Pharmacology 1996 cited by 615

  20. Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

    Authors: Tito Fojo, Sham Mailankody, Andrew W. Lo - JAMA Otolaryngology–Head & Neck Surgery 2014 cited by 301

  21. Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs☆

    Authors: Tito Fojo - Drug Resistance Updates 2007 cited by 187

  22. Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC

    Authors: Laurent Dercle, Matthew Fronheiser, Naiyer A. Rizvi, Matthew D. Hellmann, Sabine Maier, Wendy Hayes, Hao Yang, Pingzhen Guo, Tito Fojo, Lawrence H. Schwartz, Binsheng Zhao, David Leung - Journal of Thoracic Oncology 2023 cited by 25

  23. Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization

    Authors: Paraskevi Giannakakou, Dan L. Sackett, Yoon‐Koo Kang, Zhirong Zhan, Jeroen Buters, Tito Fojo, Marianne S. Poruchynsky - Journal of Biological Chemistry 1997 cited by 682

  24. A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

    Authors: Paraskevi Giannakakou, Rick Gussio, Eva Nogales, Kenneth H. Downing, Daniel Zaharevitz, Birgit Bollbuck, George Poy, Dan L. Sackett, K. C. Nicolaou, Tito Fojo - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 477